Megan Brandt

Megan Brandt brings more than 15 years of medical device leadership to the organization with a proven track record for securing multiple FDA and international regulatory approvals for a novel, innovative technologies. She has extensive experience in building and leading functional teams in Quality, Regulatory, Clinical, and Operations. Prior to joining Cardionomic, Megan held various leadership positions including Sr. Vice President of Clinical and Regulatory Affairs at Metavention, Inc., Sr. Vice President, Medical Affairs & Healthcare Policy at CHF Solutions, and Vice President, Quality & Regulatory Affairs at Cardiovascular Systems, Inc. Ms. Brandt earned her B.S. in Biochemistry and Microbiology from Minnesota State University-Mankato and is a certified quality auditor.